These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 6094046
21. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. Portale AA, Booth BE, Halloran BP, Morris RC. J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151 [Abstract] [Full Text] [Related]
22. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients. Irzyniec T, Boryń M, Kasztalska J, Nowak-Kapusta Z, Maciejewska-Paszek I, Grochowska-Niedworok E. Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861 [Abstract] [Full Text] [Related]
23. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group. Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027 [Abstract] [Full Text] [Related]
24. [Response of vitamin D metabolites to calcium restriction in hypercalciuric renal lithiasis]. Saro Gutiérrez G, Riancho Moral JA, Amado Señaris JA, Pracht Ferrer C, González Macías J. Med Clin (Barc); 1990 Mar 17; 94(10):361-3. PubMed ID: 2159577 [Abstract] [Full Text] [Related]
25. An experimental human model of 1,25-dihydroxyvitamin D-mediated hypercalciuria. Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW. J Clin Endocrinol Metab; 1984 Aug 17; 59(2):202-6. PubMed ID: 6330152 [Abstract] [Full Text] [Related]
28. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women. Packer E, Holloway L, Newhall K, Kanwar G, Butterfield G, Marcus R. J Bone Miner Res; 1990 Aug 17; 5(8):877-84. PubMed ID: 2173358 [Abstract] [Full Text] [Related]
30. [A study of calcium metabolism in calcium-containing stone formers]. Ikeda M, Ohmori A. Nihon Hinyokika Gakkai Zasshi; 1995 Aug 17; 86(8):1313-21. PubMed ID: 7474614 [Abstract] [Full Text] [Related]
32. Biochemical changes before and during oral calcium tolerance test in calcium stone formers. Kitamura T, Hirano Y, Ueda D, Aso Y. Urol Res; 1988 Aug 17; 16(3):149-55. PubMed ID: 2842910 [Abstract] [Full Text] [Related]
38. Analysis of hypophosphatemia in calcium nephrolithiasis. Yamakawa K, Kawamura J. Mol Urol; 2000 Aug 17; 4(4):365-70. PubMed ID: 11156704 [Abstract] [Full Text] [Related]
39. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H. N Engl J Med; 1980 Feb 21; 302(8):421-6. PubMed ID: 7351950 [Abstract] [Full Text] [Related]